**Executive takeaway:** The SEC disclosures for Salesforce (CRM) and ServiceNow (NOW) show two different flavors of “durable software”: CRM is leaning into **profit + capital return** (meaningful operating margin expansion plus an enlarged $50B repurchase authorization), while NOW is showing **contracted-demand acceleration** (FY2025 RPO up 27% and cRPO up 25% Y/Y) with a platform narrative explicitly built around turning AI “insights” into governed workflow execution. ["operating margin…increased to approximately 22 percent"](0001108524-25-000238|0) ["aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) ["RPO…$28.2 billion…RPO and cRPO increased by 27% and 25%"](0001373715-26-000007|0) --- ## Salesforce (CRM): what the latest filings imply *between the lines* ### 1) The “AI narrative” is being used to **re-rate the core suite**, not replace it CRM’s Q3 FY26 10‑Q makes clear the company frames Agentforce as a new platform layer enabling autonomous AI agents across business functions. That’s important, but the more investable disclosure is that this sits on top of a revenue base still overwhelmingly subscription/support (≈95% of total revenues in the period) and is therefore being monetized via the installed base, not a moonshot product P&L. ["introduced Agentforce…enables companies to build and deploy AI agents"](0001108524-25-000238|0) ["Subscription and support revenues accounted for approximately 95 percent"](0001108524-25-000238|0) **Alpha “tell”:** when a company’s hottest product is positioned as a “layer” on an existing platform, the near-term economic win tends to be **attach + expansion** (higher wallet share, lower churn) rather than a brand-new standalone revenue stream—meaning multiples can fall faster than fundamentals in any software risk-off tape. ### 2) Contracted revenue visibility is **healthy Y/Y**, but sequential RPO compression is a nuance the market often misses As of **Oct 31, 2025**, CRM disclosed total remaining performance obligation (RPO) of **$59.5B** (+12% Y/Y) and current RPO of **$29.4B** (+11% Y/Y). ["Total remaining performance obligation…$59.5 billion…increase of 12 percent year-over-year"](0001108524-25-000238|0) ["Current remaining performance obligation…$29.4 billion…increase of 11 percent year-over-year"](0001108524-25-000238|0) But the same table shows **RPO fell from $63.4B at Jan 31, 2025 to $59.5B at Oct 31, 2025** (and noncurrent RPO stepped down from $33.2B to $30.1B). ["As of October 31, 2025…Total…$59.5"](0001108524-25-000238|0) ["As of January 31, 2025…Total…$63.4"](0001108524-25-000238|0) **Alpha “between the lines”:** That pattern (Y/Y up, but sequentially down) is consistent with one (or a mix) of: (i) shorter contract durations, (ii) timing/seasonality of large renewals, or (iii) mix shift toward offerings whose recognition/contract mechanics depress reported RPO even while “business is fine.” CRM itself flags seasonality and contract mechanics as key drivers of RPO variability. ["Remaining performance obligation is influenced by…seasonality…the timing of renewals…average contract terms"](0001108524-25-000238|0) ### 3) The financial engine is increasingly “self-funding”: margins up, buybacks large, authorization expanded In the first nine months of FY26, CRM reported: - Income from operations **$6.5B** (vs **$5.4B** prior year period), with operating margin rising to **~22%** (from ~19%). ["income from operations was $6.5 billion as compared to $5.4 billion"](0001108524-25-000238|0) ["Operating margin…increased to approximately 22 percent…compared to approximately 19 percent"](0001108524-25-000238|0) - Cash provided by operations **$9.5B**. ["Cash provided by operations…was $9.5 billion"](0001108524-25-000238|0) It also disclosed **~33M shares repurchased for ~$8.7B** in the first nine months of FY26. ["repurchased approximately 33 million shares…for approximately $8.7 billion"](0001108524-25-000238|0) And—most importantly as a signal—CRM expanded its buyback authorization: in September 2025, the board authorized an additional **$20.0B**, bringing total authorization to **$50.0B** (no fixed expiration). ["authorized an additional $20.0 billion…aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) **Alpha “tell”:** in software sell-offs, the market often treats repurchases as cosmetic. Here, the authorization size and “no expiration” language suggests CRM is underwriting a multi-year *bid* under the equity—particularly valuable when sentiment-driven drawdowns detach from contracted demand. ### 4) Guidance + disclosures imply the company is managing to a “profitable growth” playbook In its Q3 FY26 earnings exhibit (furnished via 8‑K), CRM guided FY26 revenue to **$41.45B–$41.55B**, GAAP operating margin **20.3%**, and operating cash flow growth **~13%–14%**. ["Revenue…$41.45 - $41.55 billion"](0001108524-25-000234|1) ["Operating margin…20.3%"](0001108524-25-000234|1) ["Operating cash flow growth…Approximately 13% - 14%"](0001108524-25-000234|1) That same exhibit emphasizes cRPO and RPO levels and frames them as pipeline signals. ["cRPO…up 11%…$29.4 billion"](0001108524-25-000234|1) ["RPO climbs 12% to nearly $60B"](0001108524-25-000234|1) --- ## ServiceNow (NOW): what the latest filings imply *between the lines* ### 1) NOW’s key “software durability” proof is the **RPO stack accelerating** NOW disclosed (FY25, as of **Dec 31, 2025**) total RPO of **$28.2B**, with **46%** expected to be recognized in the next 12 months (cRPO). It also disclosed RPO and cRPO growth of **27% and 25% Y/Y**, respectively. ["As of December 31, 2025, our RPO was $28.2 billion, of which 46% represented cRPO"](0001373715-26-000007|0) ["RPO and cRPO increased by 27% and 25%"](0001373715-26-000007|0) **Alpha “tell”:** In risk-off software tapes, high-quality names often get sold as if backlog is “just accounting.” But RPO is contracted revenue not yet recognized; accelerating RPO growth (and high cRPO conversion) is one of the cleanest disclosure-based rebuttals to “demand is falling apart” narratives—especially when management also details the *drivers* of RPO variability (FX, contract duration, renewal timing, etc.). ["Factors that may cause our RPO to vary…Foreign currency…Timing of contract renewals…Contract duration"](0001373715-26-000007|0) ### 2) The filing makes a very specific AI argument: **AI creates data; workflows create outcomes** NOW’s FY25 10‑K spends unusual effort articulating that “AI models” alone do not execute business processes; enterprises need orchestration, governance, and the execution layer across systems of record—precisely what the ServiceNow platform claims to provide. ["AI excels at analyzing data…requires infrastructure that can orchestrate action across systems, enforce governance policies"](0001373715-26-000007|0) ["connects AI-generated insights to the operational systems and processes where work actually gets done"](0001373715-26-000007|0) That’s not marketing fluff—this framing is effectively positioning NOW as the **control plane** for enterprise AI execution (which tends to be stickier and less discretionary than “nice to have” AI features). ### 3) NOW is pairing growth with cash generation; free cash flow is a core part of the story NOW’s FY25 10‑K defines free cash flow (non‑GAAP) and provides a multi-year bridge: - FY25 GAAP net cash provided by operating activities: **$5.444B** - FY25 non‑GAAP free cash flow: **$4.636B** ["GAAP net cash provided by operating activities…$5,444"](0001373715-26-000007|0) ["Non-GAAP free cash flow…$4,636"](0001373715-26-000007|0) **Computed (from the filing):** FY25 free cash flow margin ≈ **34.9%** (FCF $4.636B ÷ revenue $13.278B). ["Non-GAAP free cash flow…$4,636"](0001373715-26-000007|0) ["Total revenues…$13,278"](0001373715-26-000007|0) That’s the type of cash efficiency that tends to get mispriced when software baskets de-rate indiscriminately. ### 4) Buybacks are scaling with maturity; authorization expanded again after year-end NOW disclosed it repurchased **~10.3M shares for $1.8B** in FY25 and that (i) ~$1.4B remained under authorization as of Dec 31, 2025, and (ii) in **Jan 2026** the board authorized an additional **$5.0B** in repurchases. ["repurchased approximately 10.3 million…for $1.8 billion"](0001373715-26-000007|0) ["As of December 31, 2025…approximately $1.4 billion…remained"](0001373715-26-000007|0) ["In January 2026…authorized an additional $5.0 billion"](0001373715-26-000007|0) ### 5) Enterprise “upmarket gravity” is visible in disclosed customer concentration metrics NOW reported **603 customers with ACV > $5M** as of Dec 31, 2025 (up from 502 and 420 in prior years). ["We had 603, 502, and 420 customers with ACV greater than $5 million"](0001373715-26-000007|0) **Alpha “tell”:** This kind of disclosed upmarket expansion is often the hidden stabilizer in downturns: large customers may elongate cycles, but they rarely rip-and-replace workflow infrastructure once embedded. --- ## Cross-company read-through: why a broad “software sell-off” can be an overreaction *based on disclosures* 1) **Both companies have unusually high forward visibility for software**—but NOW’s contracted-demand acceleration (RPO +27% Y/Y) is the cleaner “demand still strong” signal, while CRM’s signal is more “stable + returning capital” (RPO +12% Y/Y plus major repurchases). ["RPO…increased by 27%"](0001373715-26-000007|0) ["RPO…increase of 12 percent year-over-year"](0001108524-25-000238|0) ["repurchased…33 million shares…$8.7 billion"](0001108524-25-000238|0) 2) **AI monetization is being positioned differently:** - CRM is explicitly highlighting Agentforce + data as momentum drivers and tying them to ARR disclosure in its furnished earnings exhibit. ["Agentforce and Data 360…ARR reached nearly $1.4 billion"](0001108524-25-000234|1) - NOW is arguing (in the 10‑K narrative) it is the execution/governance layer for AI, with Now Assist and AI agents embedded across platform workflows. ["Now Assist…range of AI tools"](0001373715-26-000007|0) ["AI governance tools…monitoring and guardrails"](0001373715-26-000007|0) 3) **If the market is selling “AI software” as one bucket, it’s missing the risk split:** the higher-risk part is “AI as a feature” that can be replicated; the lower-risk part is “AI as an operating system for workflows + governance” (NOW’s thesis) or “AI as an attach layer across a dominant CRM footprint with improving margins and massive buybacks” (CRM’s thesis). ["orchestrate action across systems…governance policies"](0001373715-26-000007|0) ["reducing our operating expenses to improve our operating margin"](0001108524-25-000238|0) ["aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) --- ## A few “watch this next” items that can create mispricing (still SEC-grounded) - **CRM:** Track whether sequential RPO contraction persists even as Y/Y remains positive—because management explicitly states RPO can be distorted by seasonality, renewals, FX, contract terms, and acquisitions (so headlines can mislead). ["Remaining performance obligation is influenced by…seasonality…the timing of renewals…average contract terms…foreign currency exchange rates"](0001108524-25-000238|0) - **NOW:** The filing’s AI strategy is tightly coupled to “governance/guardrails” and regulated-market support; upside is that this pushes budgets into “must-do” risk/compliance workflow categories, but it also means execution risk if AI regulation costs or third‑party AI dependencies rise. ["AI governance tools include integrated monitoring and guardrails"](0001373715-26-000007|0) ["availability…performance and pricing of third-party hardware and software equipment and technical infrastructure"](0001373715-26-000007|0) If you want, I can build a compact SEC-cited “scorecard” (RPO/cRPO growth, operating margin trend, cash flow yield proxies, buyback capacity) for CRM vs NOW using only the specific figures disclosed above.

**Executive takeaway:** The SEC disclosures for Salesforce (CRM) and ServiceNow (NOW) show two different flavors of “durable software”: CRM is leaning into **profit + capital return** (meaningful operating margin expansion plus an enlarged $50B repurchase authorization), while NOW is showing **contracted-demand acceleration** (FY2025 RPO up 27% and cRPO up 25% Y/Y) with a platform narrative explicitly built around turning AI “insights” into governed workflow execution. ["operating margin…increased to approximately 22 percent"](0001108524-25-000238|0) ["aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) ["RPO…$28.2 billion…RPO and cRPO increased by 27% and 25%"](0001373715-26-000007|0) --- ## Salesforce (CRM): what the latest filings imply *between the lines* ### 1) The “AI narrative” is being used to **re-rate the core suite**, not replace it CRM’s Q3 FY26 10‑Q makes clear the company frames Agentforce as a new platform layer enabling autonomous AI agents across business functions. That’s important, but the more investable disclosure is that this sits on top of a revenue base still overwhelmingly subscription/support (≈95% of total revenues in the period) and is therefore being monetized via the installed base, not a moonshot product P&L. ["introduced Agentforce…enables companies to build and deploy AI agents"](0001108524-25-000238|0) ["Subscription and support revenues accounted for approximately 95 percent"](0001108524-25-000238|0) **Alpha “tell”:** when a company’s hottest product is positioned as a “layer” on an existing platform, the near-term economic win tends to be **attach + expansion** (higher wallet share, lower churn) rather than a brand-new standalone revenue stream—meaning multiples can fall faster than fundamentals in any software risk-off tape. ### 2) Contracted revenue visibility is **healthy Y/Y**, but sequential RPO compression is a nuance the market often misses As of **Oct 31, 2025**, CRM disclosed total remaining performance obligation (RPO) of **$59.5B** (+12% Y/Y) and current RPO of **$29.4B** (+11% Y/Y). ["Total remaining performance obligation…$59.5 billion…increase of 12 percent year-over-year"](0001108524-25-000238|0) ["Current remaining performance obligation…$29.4 billion…increase of 11 percent year-over-year"](0001108524-25-000238|0) But the same table shows **RPO fell from $63.4B at Jan 31, 2025 to $59.5B at Oct 31, 2025** (and noncurrent RPO stepped down from $33.2B to $30.1B). ["As of October 31, 2025…Total…$59.5"](0001108524-25-000238|0) ["As of January 31, 2025…Total…$63.4"](0001108524-25-000238|0) **Alpha “between the lines”:** That pattern (Y/Y up, but sequentially down) is consistent with one (or a mix) of: (i) shorter contract durations, (ii) timing/seasonality of large renewals, or (iii) mix shift toward offerings whose recognition/contract mechanics depress reported RPO even while “business is fine.” CRM itself flags seasonality and contract mechanics as key drivers of RPO variability. ["Remaining performance obligation is influenced by…seasonality…the timing of renewals…average contract terms"](0001108524-25-000238|0) ### 3) The financial engine is increasingly “self-funding”: margins up, buybacks large, authorization expanded In the first nine months of FY26, CRM reported: - Income from operations **$6.5B** (vs **$5.4B** prior year period), with operating margin rising to **~22%** (from ~19%). ["income from operations was $6.5 billion as compared to $5.4 billion"](0001108524-25-000238|0) ["Operating margin…increased to approximately 22 percent…compared to approximately 19 percent"](0001108524-25-000238|0) - Cash provided by operations **$9.5B**. ["Cash provided by operations…was $9.5 billion"](0001108524-25-000238|0) It also disclosed **~33M shares repurchased for ~$8.7B** in the first nine months of FY26. ["repurchased approximately 33 million shares…for approximately $8.7 billion"](0001108524-25-000238|0) And—most importantly as a signal—CRM expanded its buyback authorization: in September 2025, the board authorized an additional **$20.0B**, bringing total authorization to **$50.0B** (no fixed expiration). ["authorized an additional $20.0 billion…aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) **Alpha “tell”:** in software sell-offs, the market often treats repurchases as cosmetic. Here, the authorization size and “no expiration” language suggests CRM is underwriting a multi-year *bid* under the equity—particularly valuable when sentiment-driven drawdowns detach from contracted demand. ### 4) Guidance + disclosures imply the company is managing to a “profitable growth” playbook In its Q3 FY26 earnings exhibit (furnished via 8‑K), CRM guided FY26 revenue to **$41.45B–$41.55B**, GAAP operating margin **20.3%**, and operating cash flow growth **~13%–14%**. ["Revenue…$41.45 - $41.55 billion"](0001108524-25-000234|1) ["Operating margin…20.3%"](0001108524-25-000234|1) ["Operating cash flow growth…Approximately 13% - 14%"](0001108524-25-000234|1) That same exhibit emphasizes cRPO and RPO levels and frames them as pipeline signals. ["cRPO…up 11%…$29.4 billion"](0001108524-25-000234|1) ["RPO climbs 12% to nearly $60B"](0001108524-25-000234|1) --- ## ServiceNow (NOW): what the latest filings imply *between the lines* ### 1) NOW’s key “software durability” proof is the **RPO stack accelerating** NOW disclosed (FY25, as of **Dec 31, 2025**) total RPO of **$28.2B**, with **46%** expected to be recognized in the next 12 months (cRPO). It also disclosed RPO and cRPO growth of **27% and 25% Y/Y**, respectively. ["As of December 31, 2025, our RPO was $28.2 billion, of which 46% represented cRPO"](0001373715-26-000007|0) ["RPO and cRPO increased by 27% and 25%"](0001373715-26-000007|0) **Alpha “tell”:** In risk-off software tapes, high-quality names often get sold as if backlog is “just accounting.” But RPO is contracted revenue not yet recognized; accelerating RPO growth (and high cRPO conversion) is one of the cleanest disclosure-based rebuttals to “demand is falling apart” narratives—especially when management also details the *drivers* of RPO variability (FX, contract duration, renewal timing, etc.). ["Factors that may cause our RPO to vary…Foreign currency…Timing of contract renewals…Contract duration"](0001373715-26-000007|0) ### 2) The filing makes a very specific AI argument: **AI creates data; workflows create outcomes** NOW’s FY25 10‑K spends unusual effort articulating that “AI models” alone do not execute business processes; enterprises need orchestration, governance, and the execution layer across systems of record—precisely what the ServiceNow platform claims to provide. ["AI excels at analyzing data…requires infrastructure that can orchestrate action across systems, enforce governance policies"](0001373715-26-000007|0) ["connects AI-generated insights to the operational systems and processes where work actually gets done"](0001373715-26-000007|0) That’s not marketing fluff—this framing is effectively positioning NOW as the **control plane** for enterprise AI execution (which tends to be stickier and less discretionary than “nice to have” AI features). ### 3) NOW is pairing growth with cash generation; free cash flow is a core part of the story NOW’s FY25 10‑K defines free cash flow (non‑GAAP) and provides a multi-year bridge: - FY25 GAAP net cash provided by operating activities: **$5.444B** - FY25 non‑GAAP free cash flow: **$4.636B** ["GAAP net cash provided by operating activities…$5,444"](0001373715-26-000007|0) ["Non-GAAP free cash flow…$4,636"](0001373715-26-000007|0) **Computed (from the filing):** FY25 free cash flow margin ≈ **34.9%** (FCF $4.636B ÷ revenue $13.278B). ["Non-GAAP free cash flow…$4,636"](0001373715-26-000007|0) ["Total revenues…$13,278"](0001373715-26-000007|0) That’s the type of cash efficiency that tends to get mispriced when software baskets de-rate indiscriminately. ### 4) Buybacks are scaling with maturity; authorization expanded again after year-end NOW disclosed it repurchased **~10.3M shares for $1.8B** in FY25 and that (i) ~$1.4B remained under authorization as of Dec 31, 2025, and (ii) in **Jan 2026** the board authorized an additional **$5.0B** in repurchases. ["repurchased approximately 10.3 million…for $1.8 billion"](0001373715-26-000007|0) ["As of December 31, 2025…approximately $1.4 billion…remained"](0001373715-26-000007|0) ["In January 2026…authorized an additional $5.0 billion"](0001373715-26-000007|0) ### 5) Enterprise “upmarket gravity” is visible in disclosed customer concentration metrics NOW reported **603 customers with ACV > $5M** as of Dec 31, 2025 (up from 502 and 420 in prior years). ["We had 603, 502, and 420 customers with ACV greater than $5 million"](0001373715-26-000007|0) **Alpha “tell”:** This kind of disclosed upmarket expansion is often the hidden stabilizer in downturns: large customers may elongate cycles, but they rarely rip-and-replace workflow infrastructure once embedded. --- ## Cross-company read-through: why a broad “software sell-off” can be an overreaction *based on disclosures* 1) **Both companies have unusually high forward visibility for software**—but NOW’s contracted-demand acceleration (RPO +27% Y/Y) is the cleaner “demand still strong” signal, while CRM’s signal is more “stable + returning capital” (RPO +12% Y/Y plus major repurchases). ["RPO…increased by 27%"](0001373715-26-000007|0) ["RPO…increase of 12 percent year-over-year"](0001108524-25-000238|0) ["repurchased…33 million shares…$8.7 billion"](0001108524-25-000238|0) 2) **AI monetization is being positioned differently:** - CRM is explicitly highlighting Agentforce + data as momentum drivers and tying them to ARR disclosure in its furnished earnings exhibit. ["Agentforce and Data 360…ARR reached nearly $1.4 billion"](0001108524-25-000234|1) - NOW is arguing (in the 10‑K narrative) it is the execution/governance layer for AI, with Now Assist and AI agents embedded across platform workflows. ["Now Assist…range of AI tools"](0001373715-26-000007|0) ["AI governance tools…monitoring and guardrails"](0001373715-26-000007|0) 3) **If the market is selling “AI software” as one bucket, it’s missing the risk split:** the higher-risk part is “AI as a feature” that can be replicated; the lower-risk part is “AI as an operating system for workflows + governance” (NOW’s thesis) or “AI as an attach layer across a dominant CRM footprint with improving margins and massive buybacks” (CRM’s thesis). ["orchestrate action across systems…governance policies"](0001373715-26-000007|0) ["reducing our operating expenses to improve our operating margin"](0001108524-25-000238|0) ["aggregate total authorization of $50.0 billion"](0001108524-25-000238|0) --- ## A few “watch this next” items that can create mispricing (still SEC-grounded) - **CRM:** Track whether sequential RPO contraction persists even as Y/Y remains positive—because management explicitly states RPO can be distorted by seasonality, renewals, FX, contract terms, and acquisitions (so headlines can mislead). ["Remaining performance obligation is influenced by…seasonality…the timing of renewals…average contract terms…foreign currency exchange rates"](0001108524-25-000238|0) - **NOW:** The filing’s AI strategy is tightly coupled to “governance/guardrails” and regulated-market support; upside is that this pushes budgets into “must-do” risk/compliance workflow categories, but it also means execution risk if AI regulation costs or third‑party AI dependencies rise. ["AI governance tools include integrated monitoring and guardrails"](0001373715-26-000007|0) ["availability…performance and pricing of third-party hardware and software equipment and technical infrastructure"](0001373715-26-000007|0) If you want, I can build a compact SEC-cited “scorecard” (RPO/cRPO growth, operating margin trend, cash flow yield proxies, buyback capacity) for CRM vs NOW using only the specific figures disclosed above.